Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Bases de dados
País/Região como assunto
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Respir Med ; 168: 105949, 2020 07.
Artigo em Inglês | MEDLINE | ID: mdl-32469706

RESUMO

BACKGROUND: Cough is a common yet distressing symptom that results in significant health care costs from outpatient visits and related consultations. OBJECTIVE: The understanding of the pathobiology of cough in recent times has undergone an evolution with Cough hypersensitivity syndrome (CHS) being suggested in most cases of dry cough. However, in the case of productive cough, ancillary mechanisms including impaired Mucociliary clearance, in addition to hypermucosecretory bronchospastic conditions of Smoker's cough, asthma-COPD overlap, bronchiectasis, and allergic bronchopulmonary aspergillosis, need to be critically addressed while optimizing patient care with symptomatic therapy in outpatient settings of India. METHODS: In this review, evidence-based graded recommendations on use of antitussives - & protussives as a Position Paper were developed based on the Level and Quality of Scientific evidence as per Agency for Health Care and Quality (AHRQ) criteria listing and Expert opinions offered by a multidisciplinary EMA panel in India. RESULTS: Management of acute or chronic cough involves addressing common issues of environmental exposures and patient concerns before instituting supportive therapy with antitussives or bronchodilatory cough formulations containing mucoactives, anti-inflammatory, or short-acting beta-2 agonist agents. CONCLUSION: The analyses provides a real world approach to the management of acute or chronic cough in various clinical conditions with pro- or antitussive agents while avoiding their misuse in empirical settings.


Assuntos
Antitussígenos/uso terapêutico , Tosse/tratamento farmacológico , Tosse/etiologia , Aspergilose Broncopulmonar Alérgica/complicações , Asma/complicações , Bronquiectasia/complicações , Broncodilatadores/uso terapêutico , Tosse/diagnóstico , Tosse/economia , Medicina Baseada em Evidências , Expectorantes/uso terapêutico , Diretrizes para o Planejamento em Saúde , Humanos , Índia , Erros de Medicação/prevenção & controle , Depuração Mucociliar , Doença Pulmonar Obstrutiva Crônica/complicações , Fumar/efeitos adversos
2.
J Assoc Physicians India ; 41(3): 144-6, 1993 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-8226596

RESUMO

Cardiopulmonary exercise testing has a definitive place in objective evaluation of the subjective sensation of breathlessness. In the present study 21 patients with COPD, 10 with ILD and 17 normals were subjected to stage 1 exercise testing and correlations were sought between Vo2 and work, FVC, FeV1, Ve, respiratory rate and tidal volume and between VCO2 and work. In COPD and ILD the Vo2 correlated with work, Fev1, Fvc and Ve whereas in normals it correlated with the VE but not with the FeV1 and FVC. In COPD VO2 correlated with TV though this was not the case in ILD. Thus stage 1 exercise testing can be a useful additional method to assess the disability in COPD and ILD although differentiation between these two respiratory diseases on basis of exercise testing alone may not be possible.


Assuntos
Bronquite/diagnóstico , Teste de Esforço , Doenças Pulmonares Intersticiais/diagnóstico , Pneumopatias Obstrutivas/diagnóstico , Adulto , Bronquite/fisiopatologia , Dispneia/diagnóstico , Dispneia/fisiopatologia , Feminino , Humanos , Pulmão/fisiopatologia , Doenças Pulmonares Intersticiais/fisiopatologia , Pneumopatias Obstrutivas/fisiopatologia , Medidas de Volume Pulmonar , Masculino , Oxigênio/fisiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA